GE Healthcare launches bioprocess training courses in Singapore
GE Healthcare has launched a new suite of bioprocess training courses in collaboration with a leading Singapore academic institution.
Archives for February 21, 2012
News from Patheon, CTI and PRECOS – People on the move
Outsourcing Pharma presents its weekly round-up of the latest new faces and appointments in the pharmaceutical industry, including news from Patheon, CTI and PRECOS.
ACRO warns Sunshine Act is a blockade to US drug research
ACRO has told HHS the Physician Payments Sunshine Act is “highly problematic” for drug research and CROs in the US.
India needs innovation boost to kick-start drug discovery; study
Researchers have said the outlook of drug discovery in India is “poor” after analysing intellectual property generated by CROs.
Abbott's extends in Sligo ready for its new API line
Abbott Laboratories will pump €85m ($113m) into the expansion of its API production plant in Sligo, Ireland, in preparation of the launch of its pipeline products.
Job cuts a factor in calculating GMP compliance risk; PIC/S
Regulators should consider the impact of job cuts at manufacturing sites when drafting a risk-based GMP inspection plan, PIC/S said.
Ex-AstraZeneca staff open CRO near to closed UK R&D site
Former AstraZeneca employees have created a niche drug discovery CRO near to the UK site the big pharma firm closed last year.
Pfizer and Mylan settle drug delivery patent case with Sanofi
Pfizer and Mylan have settled patent litigation with Sanofi over a pre-filled drug delivery device used to treat allergic reactions.
Aptar Pharma says new eDevices will speed up regulatory approval
Aptar Pharma says its new eDevices can help companies gain quicker regulatory approval for their nasal drug products without having to re-do clinical trials.